The BR1DGE Global Faculty
The BR1DGE program is built in collaboration with specialists in the field of autoimmune type 1 diabetes (T1D) as well as people representing patient advocacy groups and payer organizations. It’s this world-beating faculty that puts the BR1DGE content at the forefront of modern autoimmune T1D research and learnings.
Olga Kordonouri
Children’s Hospital Auf der Bult, Hannover, Germany
Jurgen Vercauteren
Department of Chronic and Metabolic Diseases, KU Leuven, Leuven, Belgium
Lars-Åke Söderlund
International Pharmaceutical Federation (FIP), Stockholm, Sweden
Moshe Phillip
Schneider Children’s Medical Center of Israel
Petah Tikva, Israel
Korey Hood
Stanford University School of Medicine
Palo Alto, California, USA
Stephen Gitelman
University of California School of Medicine, San Francisco, USA
Emanuele Bosi
Professor of Internal Medicine, Head of Diabetes, San Raffaele Vita Salute University Hospital, Milan, Italy
Riitta Veijola
Professor of Pediatrics, University of Oulu and Oulu University Hospital, Oulu, Finland
.png0/jcr:content/Frame%203868%20(5).png)
Emily K. Sims
Indiana University, Indianapolis, USA
.png/jcr:content/Group%203361839%20(1).png)
Anette Ziegler
Technical University of Munich, Munich, Germany
Alice Long
Benaroya Research Institute Washington, USA
.png/jcr:content/Frame%203868%20(1).png)
Colin Dayan
Professor of Clinical Diabetes and Metabolism Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK